April 24, 2011 – Support for an online petition entitled “Hemp Now”, calling for the immediate legalisation of industrial hemp, has snowballed with more than 300 signatories and more signing on by the day. The Hemp Now campaign wants hemp – a type of cannabis plant that does not have the intoxicating THC compound found in cannabis that is smoked or ingested to “get high” – to be legalised for its 50,000 recorded uses, including clothing, eco-friendly building materials and paper. Hemp seed and oil is also rich in vitamins and the Omega 3 and 6 essential fatty acids, leading advocates to label it a “super food”.

Tony Budden, spokesperson for Hemp Now and a partner in Hemporium, which imports hemp for use in South Africa, said: “As a company that has been manufacturing and selling hemp products for 15 years, Hemporium is tired of having to import our raw material and supporting the industry in other countries, when we can see how it has the potential to provide jobs, houses and nutrition – three very necessary and under-supplied components of our society. Hemp can do this in a way that benefits the environment too, and we feel South Africa has the potential to become a world leader in the ethical and environmental hemp industry.”

The Hemp Now petition calls for hemp to be legalised immediately across South Africa to join the 28 countries worldwide that have already legalised the growth of the plant for industrial purposes.

The campaign also emphasises that it wants to put an end to “botanical racism”, arguing that hemp is unfairly viewed as a drug whereas it has no intoxicating effects and its legalisation would help to create a more sustainable economy and a green future for South Africa.

The clout the petition will have is still unknown, but Budden is hoping for long-term positive results: “The petition is part of a larger movement that is currently building a lot of momentum with regards to hemp in South Africa. It is effective in giving a voice to supporters of hemp who often feel frustrated by the stagnation of hemp research and don’t have a way of communicating their opinions regarding this valuable resource.” Source.

April 24, 2011 – WASHINGTON — The medical marijuana industry is beginning to show its age.

After humble California beginnings in 1996, 15 states and the District of Columbia now have legalized marijuana use for ill patients who have a doctor’s recommendation.

Medical marijuana has been found to help with chronic pain, nausea and other symptoms of diseases including cancer, muscular dystrophy and AIDS. Nearly 25 million Americans are medically eligible to buy marijuana.

Sales are expected to hit $1.7 billion this year. Just last week, a San Francisco-based outfit, the ArcView Group, formed the industry’s first investment network to link cannabis entrepreneurs to qualified investors with seed money.

“It doesn’t take a rocket scientist to realize that this industry is growing and that there are untold riches to be made here,” said Troy Dayton, chief executive of the ArcView Group.

In coming months, Arizona, New Jersey, Rhode Island and the District of Columbia will launch programs, joining eight states where medical marijuana is sold legally. Those states are California, Colorado, Maine, Michigan, Montana, Oregon, Washington and New Mexico.

But around the country, some law enforcement officials have expressed concern that medical marijuana could be obtained by relatively healthy people who could get a recommendation from a physician by lying or overstating their pain and suffering.

They also worry that some dispensaries could grow more marijuana than their patients could consume, leaving an excess that could make its way to the illegal market.

While legal for medical purposes in many states, marijuana remains an illegal controlled substance under federal law, although since 2009, the Justice Department has said it won’t prosecute medical marijuana use within the bounds of states’ laws.

With more than 1,500 growing operations and dispensaries nationwide, the medical marijuana industry has defied the recession and prospered even as the broader economy stalled.

Regulatory friction

Strong public support has helped fuel the industry’s eastward expansion, but that growth has also brought growing pains.

Industry reps say section 280E of the Internal Revenue Code unfairly bars legal medical marijuana operations from deducting business expenses from their income taxes. Dispensaries nationwide are facing Internal Revenue Service audits over the measure.

Other dispensaries have found that banks won’t maintain their business accounts, fearing federal scrutiny over reporting requirements for ties to businesses that violate federal law.

The National Cannabis Industry Association was formed late last year to help address these concerns. The trade group recently held its first national lobby day, visiting lawmakers on Capitol Hill as part of a push for greater legislative clout.

“These kinds of days are necessary, because it puts a face on the industry,” said Rep. Jared Polis, D-Colo., one of the industry’s staunchest supporters.

While 76 percent of medical marijuana sales nationally are generated in California, Colorado has the nation’s fastest-growing market. More than 131,000 Coloradans are registered marijuana patients, up from 7,000 in 2008.

Colorado Dispensary Services, which operates three dispensaries and three commercial growing operations, has had five different bank accounts in 3 1/2 years, owing to state regulatory friction. Owner Jill Lamoureux said it’s impossible to manage nearly 50 employees and $120,000 in monthly payroll without a bank account. State regulators have taken notice.

“These regulators need to see our bank accounts, and if we do not have access to banking, it makes it impossible for them to regulate,” Lamoureux said. “Frustrating is an understatement to say how difficult it is to run a business” without banking services.

Last year, Polis and seven other Democratic lawmakers wrote a letter asking the U.S. Treasury to declare that it wouldn’t target banks with account holders that operate in compliance with state medical marijuana laws. Federal regulators deferred, arguing that banks must make those calls themselves.

Polis said he’ll introduce legislation soon that clarifies banks’ responsibilities when dealing with marijuana dispensaries. He said support for the issue is bipartisan, citing Republican Reps. Ron Paul of Texas and Dana Rohrabacher of California as sympathetic to the industry’s plight. Source